It is a pharma private limited company based in Vadodara, Gujarat, India, established in 2010.
2010 | Vadodara, Gujarat, India | ActiveNovotek Formulations Private Limited, a active private limited company, was established on 27 October 2010 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2010PTC062760. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Roma Nileshbhai Shah (Director), Arun Raghavjibhai Raiyani (Director), Rakshit Ramjibhai Talaviya (Director). Past directors included Ojasbhai Ravjibhai Patel. Its latest AGM occurred on 27 September 2019, with the balance sheet filed on 31 March 2019. It is based at 106, Rajmandir Apartment, 62, Alkapuri Society, R C Dutt Road,, Vadodara, Gujarat, 390007.
U24230GJ2010PTC062760
062760
27 October 2010
₹0.20 M
₹0.15 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Novotek Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Roma Nileshbhai Shah | Director | 28 Dec 2012 | Current |
| Arun Raghavjibhai Raiyani | Director | 28 Dec 2012 | Current |
| Rakshit Ramjibhai Talaviya | Director | 28 Dec 2012 | Current |
| Nileshkumar Manilal Shah | Director | 27 Oct 2010 | Current |
| Jyotindra Raghavjibhai Raiyani | Director | 28 Dec 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Dec 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novotek Formulations Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 188.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Novotek Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Novotek Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novotek Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novotek Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Novotek Formulations Private Limited last Annual general meeting of members was held on 27 Sep 2019 as per latest MCA records. was documented.
The activity Novotek Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ahmedabad. was completed.
Progress on Roma Nileshbhai Shah was appointed as a Director was appointed as a Director on 28 Dec 2012 & has been associated with this company since 12 years 11 months . was documented.
Arun Raghavjibhai Raiyani was appointed as a Director was appointed as a Director on 28 Dec 2012 & has been associated with this company since 12 years 11 months . was recorded as a recent event.
Progress on Rakshit Ramjibhai Talaviya was appointed as a Director was appointed as a Director on 28 Dec 2012 & has been associated with this company since 12 years 11 months . was documented.
Progress on Jyotindra Raghavjibhai Raiyani was appointed as a Director was appointed as a Director on 28 Dec 2012 & has been associated with this company since 12 years 11 months . was documented.
The CIN of Novotek Formulations Private Limited is U24230GJ2010PTC062760.
Novotek Formulations Private Limited is headquartered at 106, Rajmandir Apartment, 62, Alkapuri Society, R C Dutt Road,, Vadodara, Gujarat, 390007.
Novotek Formulations Private Limited was incorporated on 27 October 2010.
The current directors of Novotek Formulations Private Limited are
The primary industry of Novotek Formulations Private Limited is Manufacturing.
Novotek Formulations Private Limited is unlisted.
The authorized capital of Novotek Formulations Private Limited is ₹0.20 M, and the paid-up capital is ₹0.15 M.
The compliance status of Novotek Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX